Bayer to acquire Conceptus for $1.1 billion

Acquisition will give Bayer control of Essure permanent birth-control procedure

LEVERKUSEN, Germany — Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

Bayer said its $31-per-share purchase of the Mountain View, Calif.-based company would allow it to expand its selection of contraception products. Conceptus makes Essure, a non-surgical permanent birth-control method, and Bayer said it would allow the company to offer a complete range of short-term, long-term and permanent contraceptive methods for women.

"Bayer is committed to augmenting its organic growth with strategic bolt-on acquisitions," Bayer AG CEO Marijn Dekkers said. "The acquisition of Conceptus represents an excellent fit for our HealthCare business, specifically in the United States, the world's most important healthcare market."

 

Recommended stories

Login or Register to post a comment.